Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N. O. Pozdnyakov"'
Autor:
N. O. Pozdnyakov, I. N. Kagarmanyan, A. E. Miroshnikov, E. S. Emelyanov, A. A. Gruzdeva, A. M. Sirotkina, I. A. Dukhanina, A. A. Milkina, A. A. Khokhlov, S. O. Pozdnyakov
Publikováno v:
Acta Biomedica Scientifica, Vol 5, Iss 3, Pp 13-23 (2020)
In this article, we analyze the role of different variants of the KCNJ11, TCF7L2, SLC22A1, SLC22A3, CYP2C9, CYP2C8, PPARγ genes polymorphisms in efficacy of diabetes mellitus pharmacotherapy. T allele of the KCNJ11 rs2285676 gene polymorphism and G
Externí odkaz:
https://doaj.org/article/90bffad3c345457fba2a041e4979c0cf
Autor:
A. L. Khokhlov, A. N. Yavorsky, N. O. Pozdnyakov, J. V. Rybachkova, E. S. Emelianov, A. A. Khokhlov, A. E. Miroshnikov, S. O. Pozdnyakov
Publikováno v:
Архивъ внутренней медицины, Vol 8, Iss 1, Pp 45-52 (2018)
The complexity of therapy of lipid metabolism disorders is not only in comorbidity and polypragmasia, but also in predicting a genetically determined response to the treatment. The aim of our work was to study the pharmacogenetics features of pharmac
Externí odkaz:
https://doaj.org/article/31bf942db4b14a65a049a70b29d53deb
Publikováno v:
Архивъ внутренней медицины, Vol 6, Iss 3, Pp 53-58 (2016)
Coronary heart disease (CHD) is a major cause of mortality. Morphological substrate of CHD in most cases is atherosclerosis, which is based on structural genes polymorphism eNOS and AGTR2. The aim of the study was to study the prevalence of eNOS and
Externí odkaz:
https://doaj.org/article/08921629dd5143edac7fbcd13fcc5630
Autor:
A. A. Mokhov, N. O. Pozdnyakov, A. L. Khokhlov, A. N. Yavorsky, A. E. Miroshnikov, Ph. A. Romanov
Publikováno v:
Kutafin Law Review. 8:3-35
The current science and research trends, as well as the development of personalized medicine, point to the need to use genetic tests in course of the study of pharmaceuticals. Pharmacogenetic testing has become indispensable when developing new pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b17684e6f5a13369c958a2067c0cd3c
https://doi.org/10.17803/2313-5395.2021.1.15.003-035
https://doi.org/10.17803/2313-5395.2021.1.15.003-035
Publikováno v:
Pharmaceutical Chemistry Journal. 54:544-546
The recently published monograph “Industrial Pharmacy: The Way to Create a Product” is devoted to topical problems in this field. The unique interdisciplinary features of drug development require specialists in this industry that possess a high l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5a2762132360551aa1065c8c01c1129
https://doi.org/10.1007/s11094-020-02235-6
https://doi.org/10.1007/s11094-020-02235-6
Autor:
S. A Gerasimchuk, K. S Manko, E. G Dubovik, E. A Voronina, N. O. Pozdnyakov, A. L. Khokhlov, A. E. Miroshnikov, A. A. Khokhlov, Yu. V Rybachkova
Publikováno v:
Medical Journal of the Russian Federation. 24:299-305
Objective: Drug Amlodipine+Valsartan is safe and effective for comprehensive treatment of arterial hypertension patients taken combined therapy by prescription. The development of new fix drug combination amlodipine and valsartan will provide in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99eaa7868b010e03df0853899215c202
https://doi.org/10.18821/0869-2106-2018-24-6-299-305
https://doi.org/10.18821/0869-2106-2018-24-6-299-305